Jobard, E., Trédan, O., Bachelot, T., Vigneron, A. M., Aït-Oukhatar, C. M., Arnedos, M., . . . Elena-Herrmann, B. (2017). Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients. Oncotarget.
Style de citation ChicagoJobard, Elodie, et al. "Longitudinal Serum Metabolomics Evaluation of Trastuzumab and Everolimus Combination As Pre-operative Treatment for HER-2 Positive Breast Cancer Patients." Oncotarget 2017.
Style de citation MLAJobard, Elodie, et al. "Longitudinal Serum Metabolomics Evaluation of Trastuzumab and Everolimus Combination As Pre-operative Treatment for HER-2 Positive Breast Cancer Patients." Oncotarget 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.